Neurite length in <i>Thap1</i>^<i>+/-</i> and <i>Thap1</i>^{<i>C54Y/+</i>} E16 primary striatal neurons <i>in vitro</i> is decreased relative to neurons from WT m... by Zuchra Zakirova (431614)

Data_Sheet_1_Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nation... by Hsin-Hsu Wu (440386)

“…</p>Results<p>50,854 (56.0%) of them were male with a mean age of 74.9 (SD, 10.4) years. …”

Results of peptide toxicity of each diet. by Fatima Dikhanbayeva (11501962)

“…<p>Values are given as mean ± SD for a total of 50 animals. Control group (I) - 0.295 nm, Curd mass (II)– 0.122 nm, Curd mass with flaxseed flour (III)– 0.113 nm, curd mass with celery root powder (IV) - 0.114 nm, Curd mass with bee bread (V)– 0.127 nm. …”

The results of assay of blood serum biochemical parameters after experiment. by Fatima Dikhanbayeva (11501962)

“…*Values are given as mean ± SD for a total of 50 animals. p<0, 05 versus mice fed regular diet.…”

Decreased expression levels of SPI-1 genes in <i>bipA</i>-deleted strain at 20°C. by Eunsil Choi (8271039)

Variations in the mean force coefficients. by Shantanu S. Bhat (5446082)

Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”

Macrocyclic Receptor Exhibiting Unprecedented Selectivity for Light Lanthanides by Adrián Roca-Sabio (1791607)

Subjects:

Macrocyclic Receptor Exhibiting Unprecedented Selectivity for Light Lanthanides by Adrián Roca-Sabio (1791607)

Subjects:

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day after enrolment. by Nattapat Nitinai (17896679)

Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”

Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor by Beatrice Noce (16540800)

Subjects:

Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer by Fan-Fan Shang (16953264)

Subjects:

How the variation in inhibitor concentration throughout one day affects the value of IC₅₀/(IC₅₀ + [R]) for different Abl1 inhibitors. by J. Roadnight Sheehan (20141887)